# 바이오스페이스 일일 뉴스 리포트 - 2026년 02월 13일


## 주요 헤드라인

1. **Flu Vaccine Rejection Imperils Moderna’s Breakeven Plans (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/flu-vaccine-rejection-imperils-modernas-breakeven-plans>

2. **Flu Vaccine Rejection Imperils Moderna’s Breakeven Plans (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/flu-vaccine-rejection-imperils-modernas-breakeven-plans>

3. **‘Highly Impressive’ Data Propels BridgeBio’s Achondroplasia Drug Forward (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/highly-impressive-data-propels-bridgebios-achondroplasia-drug-forward>

4. **Sanofi Shares Decline as Paul Hudson Removed as CEO, Making Way For Merck KGaA’s Belén Garijo (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sanofi-shares-decline-as-paul-hudson-removed-as-ceo-making-way-for-merck-kgaas-belen-garijo>

5. **HHS Backs Prasad Amid Moderna Flu Shot Blowback (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/hhs-backs-prasad-amid-moderna-flu-shot-blowback>

6. **Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/digital-pathology-ai-and-the-future-of-adcs-and-her2-cancer-treatment>

7. **BioMarin Bet on Amicus To Ease Voxzogo’s Decline. Will It Work? (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biomarin-bet-on-amicus-to-ease-voxzogos-decline-will-it-work>


---
*2026년 02월 13일 바이오스페이스 뉴스 피드에서 생성된 리포트*